Aradigm and CyDex Sign Development Collaboration AgreementBusiness Wire (press release), CA - 10 hours agoThese include Bristol-Myers Squibb’s Abilify(a) IM, Pfizer Animal Health’s Cerenia(a) and Geodon(a) for Injection and Vfend(a) IV, marketed globally by …
Read full story
Earthtimes.orgRapid Rise in Number of Kids Treated for BipolarEarthtimes.org - Sep 4, 2007The other half of the children were prescribed atypical antipsychotics such as Lilly's Zyprexa, J&J's Risperdal, and Bristol-Myers' Abilify and Pfizer's …
Read full story
J&J, Pfizer Profit on `Juvenile Bipolar Juggernaut' (Update2)Bloomberg - 4 hours agoBetween 2003 and 2006, US prescriptions of Bristol-Myers's Abilify for children 18 years and younger soared sevenfold to more than 1 million, Wolters Kluwer …
Read full story
Bipolar Diagnosis In Youth Rapidly ClimbingScience Daily (press release) - 8 hours ago… atypical antipsychotic medications, such as aripiprazole (Abilify) or olanzapine (Zyprexa), than other types of antipsychotics. …
Read full story
Bipolar Diagnosis in Kids Jumps 40-Fold in 10 Years, Study SaysBloomberg - 13 hours agoNearly half the children took atypical antipsychotics, such as Lilly's Zyprexa, J&J's Risperdal, AstraZeneca Plc's Seroquel, Bristol-Myers' Abilify and …
Read full story
Psychotropic Drug Makers Bankroll Prescribing Shrinks Part IILawyers and Settlements, Canada - 6 hours ago… Seroquel, by AstraZeneca; Risperdal, marketed by Johnson & Johnson subsidiary Janssen; Geodon, sold by Pfizer, and Abilify, from Bristol-Myers Squibb. …
Read full story
Psychotropic Drug Makers Bankroll Prescribing Shrinks Part ILawyers and Settlements, Canada - 5 hours agoFor the study, the researchers pooled the results of 15 studies on the atypicals Zyprexa, Risperdal, Seroquel and Abilify and among more than 5000 dementia …
Read full story
Move over lithium; FDA sanctions use of Risperdal in teensMedical Marketing and Media, NY - Aug 23, 2007Other companies applying for some similar label changes include Eli Lilly, which markets Zyprexa, and Bristol-Myers Squibb, maker of Abilify. …
Read full story
FDA approves J&J's Risperdal for use in children and teensPharma Times (subscription), UK - Aug 23, 2007It gives the company a head-start over rival drugs, namely Eli Lilly’s Zyprexa (olanzapine) and Bristol-Myers Squibb/Otsuka Pharmaceutical’s Abilify …
Read full story
CNNMoney.comFDA rejects Wyeth anti-psychotic drugCNNMoney.com - Aug 10, 2007Generic competition would drive down revenues for competing name-brand anti-psychotics, such as Abilify from Bristol-Myers Squibb (up $0.31 to $28.49, …Abilify - Google News
Read full story